BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24926542)

  • 1. Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer.
    O'Malley M; King AN; Conte M; Ellingrod VL; Ramnath N
    J Thorac Oncol; 2014 Jul; 9(7):917-926. PubMed ID: 24926542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does a Recent Cancer Diagnosis Predict Smoking Cessation? An Analysis From a Large Prospective US Cohort.
    Westmaas JL; Newton CC; Stevens VL; Flanders WD; Gapstur SM; Jacobs EJ
    J Clin Oncol; 2015 May; 33(15):1647-52. PubMed ID: 25897151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support.
    Warren GW; Sobus S; Gritz ER
    Lancet Oncol; 2014 Nov; 15(12):e568-80. PubMed ID: 25439699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis.
    Sohn HS; Kwon JW; Shin S; Kim HS; Kim H
    J Clin Pharm Ther; 2015 Dec; 40(6):661-71. PubMed ID: 26573867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials.
    Hasegawa Y; Ando M; Maemondo M; Yamamoto S; Isa S; Saka H; Kubo A; Kawaguchi T; Takada M; Rosell R; Kurata T; Ou SH
    Oncologist; 2015 Mar; 20(3):307-15. PubMed ID: 25657199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking affects treatment outcome in patients with resected esophageal squamous cell carcinoma who received chemotherapy.
    Zheng Y; Cao X; Wen J; Yang H; Luo K; Liu Q; Huang Q; Chen J; Fu J
    PLoS One; 2015; 10(4):e0123246. PubMed ID: 25874561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies.
    Qiu JX; Zhou ZW; He ZX; Zhang X; Zhou SF; Zhu S
    Drug Des Devel Ther; 2015; 9():841-66. PubMed ID: 25733806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of oncology and palliative care: a systematic review.
    Hui D; Kim YJ; Park JC; Zhang Y; Strasser F; Cherny N; Kaasa S; Davis MP; Bruera E
    Oncologist; 2015 Jan; 20(1):77-83. PubMed ID: 25480826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of smoking cessation in subjects with cancer: a 30-year review.
    Florou AN; Gkiozos IC; Tsagouli SK; Souliotis KN; Syrigos KN
    Respir Care; 2014 Dec; 59(12):1924-36. PubMed ID: 25185148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer.
    Browman GP; Wong G; Hodson I; Sathya J; Russell R; McAlpine L; Skingley P; Levine MN
    N Engl J Med; 1993 Jan; 328(3):159-63. PubMed ID: 8417381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.
    Anderson GD; Chan LN
    Clin Pharmacokinet; 2016 Nov; 55(11):1353-1368. PubMed ID: 27106177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of smoking on lung cancer treatment effectiveness: a review.
    Condoluci A; Mazzara C; Zoccoli A; Pezzuto A; Tonini G
    Future Oncol; 2016 Sep; 12(18):2149-61. PubMed ID: 27424719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of smoking on metabolic changes and effectiveness of drugs used for lung cancer.
    Perlík F
    Cent Eur J Public Health; 2020 Mar; 28(1):53-58. PubMed ID: 32228818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of CYP1A2 and CYP3A4 activity by a simplified Geneva cocktail approach in a cohort of free-living individuals: a pilot study.
    Sobsey CA; Mady N; Richard VR; LeBlanc A; Zakharov T; Borchers CH; Jagoe RT
    Front Pharmacol; 2024; 15():1232595. PubMed ID: 38370474
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiologically Based Pharmacokinetic (PBPK) Model Predictions of Disease Mediated Changes in Drug Disposition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD).
    Adiwidjaja J; Spires J; Brouwer KLR
    Pharm Res; 2024 Mar; 41(3):441-462. PubMed ID: 38351228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice patterns, experiences, and challenges of German oncology health care staff with smoking cessation in patients with cancer: a cross-sectional survey study.
    Bokemeyer F; Lebherz L; Bokemeyer C; Derksen JWG; Schulz H; Bleich C
    J Cancer Surviv; 2023 Nov; ():. PubMed ID: 38012516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stakeholder perceptions of using "opt-out" for tobacco use treatment in a cancer care setting: a qualitative evaluation of patients, providers, and desk staff.
    Ohde JW; Warner DO; Egginton JS; Hagedorn HJ
    Implement Sci Commun; 2023 Sep; 4(1):117. PubMed ID: 37730738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies.
    Fares AF; Li Y; Jiang M; Brown MC; Lam ACL; Aggarwal R; Schmid S; Leighl NB; Shepherd FA; Wang Z; Diao N; Wenzlaff AS; Xie J; Kohno T; Caporaso NE; Harris C; Ma H; Barnett MJ; Leal LF; Fernandez-Tardon G; Pérez-Ríos M; Davies MPA; Taylor F; Schöttker B; Brennan P; Zaridze D; Holcatova I; Lissowska J; Świątkowska B; Mates D; Savic M; Brenner H; Andrew A; Cox A; Field JK; Ruano-Ravina A; Shete SS; Tardon A; Wang Y; Le Marchand L; Reis RM; Schabath MB; Chen C; Shen H; Ryan BM; Landi MT; Shiraishi K; Zhang J; Schwartz AG; Tsao MS; Christiani DC; Yang P; Hung RJ; Xu W; Liu G
    Lancet Public Health; 2023 Sep; 8(9):e691-e700. PubMed ID: 37633678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of predictive factors for early relapse in patients with unresectable stage III non-small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy.
    Nam JH; Yeo CD; Park CK; Kim SK; Kim JS; Kim YH; Kim JW; Kim SJ; Lee SH; Kang HS
    Thorac Cancer; 2023 Sep; 14(26):2657-2664. PubMed ID: 37519059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking patterns and the intention to quit in German patients with cancer: study protocol for a cross-sectional observational study.
    Bokemeyer F; Lebherz L; Schulz H; Bokemeyer C; Gali K; Bleich C
    BMJ Open; 2023 Apr; 13(4):e069570. PubMed ID: 37055212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.